Slow commercialization of offline payments
The solution requires ecosystem-wide integration and operator approval before scaling.
- Scope
- Payment system operators, banks, and infrastructure partners
- Materiality
- high
Crunchfish is a Swedish technology company based in Malmö that develops software for digital payments and offline transaction functionality. Its business centers on Digital Cash and related payment infrastructure components that can be integrated by banks, payment service providers, system operators, and technology partners.
| % | |
|---|---|
| Digital Cash / governed offline payments | 45% Software and architecture for offline-capable digital payments governed by system rules. |
| Offline wallet software | 20% Wallet functionality used by payers to make payments without connectivity. |
| Offline acceptance infrastructure | 15% Components that let terminals and merchants receive offline payments. |
| Licensing and SaaS | 20% Commercial licensing models for service providers and payment ecosystem participants. |
Crunchfish sells into the payment ecosystem rather than to end consumers. Its core customers are system operators,...
Central banks and payment system operators that define rules, limits, and governance for offline payments.
Financial institutions that integrate offline wallet or acceptance functionality into their payment offerings.
Wallet platforms, switching platforms, and POS vendors that embed Crunchfish components into their stack.
Local partners that help distribute and implement the solution in specific markets.
Crunchfish is headquartered in Malmö, Sweden, and operates as a Swedish listed company...
Crunchfish’s strategy is to position offline payments as a system-level infrastructure capability, not just a wallet...
System-level deployment can scale across entire payment ecosystems.
Local partners improve market access and implementation in target regions.
Patents and architecture validation support differentiation and licensing leverage.
Crunchfish depends on adoption of a relatively new payment architecture, so commercialization risk is tied to long...
The solution requires ecosystem-wide integration and operator approval before scaling.
The company has limited revenue and ongoing development needs, so funding access matters.
Offline payment rules, CBDC design choices, and local payment governance can change.
Licensing and differentiation rely on patents and technical defensibility.
BRFH · Canned, Frozen & Preservd Fruit, Veg & Food Specialties
BCHT · Measuring & Controlling Devices, NEC
CRNX · Pharmaceutical Preparations
Crinetics Pharmaceuticals is a U.S.-based biopharmaceutical company focused on endocrine diseases and endocrine-related tumors.
ZEOX · Biological Products, (No Diagnostic Substances)
ZIVO · Biological Products, (No Diagnostic Substances)
NBIX · Biological Products, (No Diagnostic Substances)
Neurocrine Biosciences is a U.S.-based biopharmaceutical company focused on neuroscience and related endocrine disorders.
: 11/08/2026